精液参数纵向评估与活产:变异性及对治疗策略的启示
基于FAZST前瞻性队列(n=2369对夫妇),在4个美国生殖内分泌与不孕症中心评估基线和第2、4、6个月的精液参数与活产关系。按治疗分层发现,在促排卵或未治疗夫妇中精液形态、活动力、浓度和总活动精子数最低四分位与活产减少相关;宫腔内人工授精中精液量、浓度、精子数和总活动精子数最低四分位与活产减少相关;体外受精中仅低形态与活产相关。
要点
- 促排卵或未治疗夫妇中,精液形态最低四分位每100对夫妇活产减少19例(95%CI -23至-15)。
- 宫腔内人工授精中,精液浓度最低四分位每100对夫妇活产减少6例(95%CI -11至-0.1)。
- 体外受精中仅低形态与活产相关,Q1风险差-7(95%CI -14至0.2),Q2风险差-10(95%CI -17至-2.2)。
核心结论
- 在促排卵或宫腔内人工授精夫妇中精液参数至关重要,体外受精后仅低形态与活产相关。
- 当前发现可推广至不同男性生育力和夫妇生育治疗范围,为不同情境下最相关精液参数提供证据。
研究设计与样本
- 叶酸和锌补充试验(FAZST)前瞻性队列,2013至2017年在美国4个生殖内分泌与不孕症照护研究中心开展。
- 纳入寻求生育咨询的夫妇n=2369对。
- 基线和入组后第2、4、6个月评估精液量、pH、精子存活率、形态、前向和总活动力、浓度、精子数及总和前向活动精子数。
- 采用按接受生育治疗分层的对数二项模型估计精液参数四分位与活产的风险差,并考虑每人多次精液评估。
主要发现
- 仅促排卵或未治疗夫妇中39%活产,形态最低四分位风险差-19(95%CI -23至-15)/每100对夫妇,活动力风险差-13(95%CI -17至-9),浓度风险差-22(95%CI -26至-19),总活动精子数风险差-18(95%CI -22至-14)。
- 宫腔内人工授精中26%活产,精液量最低四分位风险差-6(95%CI -11至-0.4),浓度风险差-6(95%CI -11至-0.1),精子数风险差-10(95%CI -15至-4),总活动精子数风险差-7(95%CI -13至-1)。
- 体外受精中61%活产,仅形态与活产相关:Q1风险差-7(95%CI -14至0.2),Q2风险差-10(95%CI -17至-2.2)。
关键数值与推荐
- 促排卵或未治疗夫妇中,形态、活动力、浓度和总活动精子数最低四分位与活产减少相关。
- 宫腔内人工授精中,精液量、浓度、精子数和总活动精子数最低四分位与活产减少相关。
- 体外受精中仅低形态与活产相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether semen parameters are associated with live birth among couples seeking infertility treatment after accounting for semen parameter variability. DESIGN: Folic Acid and Zinc Supplementation Trial (FAZST) prospective cohort. SETTING: Four US reproductive endocrinology and infertility care study centers, 2013-2017. PATIENT(S): Couples (n = 2,369) seeking fertility consultations at 4 US infertility care study centers. INTERVENTION(S): Semen volume, pH, sperm viability, morphology, progressive and total motility, concentration, count, and total and progressive motile count assessed at baseline and at 2, 4, and 6 months after enrollment. MAIN OUTCOME MEASURE(S): Log-binomial models stratified by fertility treatment received (in vitro fertilization [IVF], intrauterine insemination [IUI], ovulation induction [OI], or no treatment) estimated risk differences (RDs) between semen parameter quartiles and live birth and accounted for multiple semen assessments per person. We accounted for abstinence time, the biological interdependence of semen parameters, and potential selection bias because of loss to follow-up. RESULT(S): Among couples using OI only or no treatment, 39% had a live birth, and relative to the highest quartile, the lowest quartiles of morphology (RD, -19 [95% CI, -23 to -15] per 100 couples), motility (RD, -13 [95% CI, -17 to -9]), concentration (RD, -22 [95% CI, -26 to -19]), and total motile count (RD, -18 [95% CI, -22 to -14]) were associated with fewer live births. For IUI, 26% had a live birth, and the lowest quartiles of volume (RD, -6 [95% CI, -11 to -0.4]), concentration (RD, -6 [95% CI, -11 to -0.1]), count (RD, -10 [95% CI, -15 to -4]), and total motile count (RD, -7 [95% CI, -13 to -1]) were associated with fewer live births. For IVF, 61% had a live birth, and only morphology (Q1 RD, -7 [95% CI, -14 to 0.2]; Q2 RD, -10 [95% CI, -17 to -2.2]) was associated with live birth. CONCLUSION(S): Semen parameters are critical in couples undergoing OI/IUI. Only low morphology was important for live birth after IVF. Although data supporting the use of semen parameters are fragmented across differing populations, current findings are generalizable across the range of male fertility and couple fertility treatments, providing evidence about which semen parameters are most relevant in which settings. CLINICAL TRIAL REGISTRATION NUMBER: NCT#01857310.
引用
- DeVilbiss EA, Sjaarda LA, Peterson CM, et al. Longitudinal semen parameter assessments and live birth: variability and implications for treatment strategies. Fertil Steril. 2022. PMID: 36192231. doi:10.1016/j.fertnstert.2022.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。